Regulus Therapeutics Inc. (RGLS)

The total Gamma Exposure (GEX) for RGLS across all expirations is -922.78 shares per 1% move, with 0 from calls and 922.78 from puts. The put-call GEX ratio of n/a reflects balanced positioning between puts and calls. The highest gamma concentration is at the Nov 21, 25 expiration with -922.78 net GEX, which may act as a pivot point for price action. Near-term exposure for Nov 21, 25 suggests possible volatility from negative gamma effects.